New measurements for hadrontherapy and space radiation: Biology

Physica Medica

Volumn 17, Issue SUPPL. 1, 2001, Pages 50-58

  Blakely, E A ^a  

^a LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

Biological effects; Clinical data; Hadrontherapy; Space radiation

Indexed keywords

CARBON; IRON; PROTON;

CANCER RISK; CENTRAL NERVOUS SYSTEM DISEASE; CONFERENCE PAPER; COSMIC RADIATION; HADRON THERAPY; HUMAN; MEDICAL RESEARCH; PROTON RADIATION; RADIATION CARCINOGENESIS; RADIATION FIELD; RADIATION HAZARD; RADIATION INJURY; RADIATION MEASUREMENT; RADIOBIOLOGY; RADIOSENSITIVITY; RADIOTHERAPY; RISK ASSESSMENT; SPACE FLIGHT;

NASA DISCIPLINE RADIATION HEALTH; NON-NASA CENTER;

ANIMALS; BIOLOGICAL MARKERS; CARBON; CELL PHYSIOLOGY; COSMIC RADIATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; HEAVY IONS; HUMANS; IRON; NEOPLASMS, RADIATION-INDUCED; PROTONS; RADIOBIOLOGY; RADIOTHERAPY; SIGNAL TRANSDUCTION; SPACE FLIGHT;

EID: 0034857240     PISSN: 11201797     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (120)

1. 6th workshop on heavy charged particle in biology and medicine
2. Neutron therapy and specific ionization
3. Overview. Late effects of normal tissues (LENT) scoring system
4. Chromosome instability syndromes, in Genetics of human cancer
5. Identification of genes involved in repair of DNA double-strand breaks in mammalian cells
6. Radiation-related brain damage and growth retardation among the prenatally exposed atomic bomb survivors
7. Studies of the mortality of atomic bomb survivors
8. A model for radiation-related cancer suggested by atomic bomb survivor data
9. Studies of the mortality of atomic bomb survivors. Report 12, part II. Noncancer mortality: 1950-1990
10. Effects of radiation on the longitudinal trends of total serum cholesterol levels in the atomic bomb survivors
11. Ionizing radiation and genetic risks. VI. Chronic multifactorial diseases: A review of epidemiological and genetical aspects of coronary heart disease, essential hypertension and diabetes mellitus
12. Ionizing radiation alters hepatic cholesterol metabolism and plasma lipoproteins in Syrian hamster
13. Ionizing radiation accelerates aortic lesion formation in fat-fed mice via SOD-inhibitable processes
14. Analysis of blood lymphocyte subsets in children living around Chernobyl exposed long-term to low doses of cesium-137 and various doses of iodine-131
15. Characteristics of the cohort of workes at the Mayak nuclear complex
16. Estimate of space radiation-induced cancer risks for international space station orbits
17. Proceedings of the impact of solar energetic particle events for the design of human space missions
18. Radiation measurements: U.S. and Russian results
19. Biomarkers of exposure, sensitivity and disease
20. Differential modulation of specific gene expression following high- and low-LET radiations
21. Effects of exposure to different types of radiation on behaviors mediated by peripheral or central systems
22. Effects of exposure to heavy particles on a behavior mediated by the central nervous system
23. Selective efficacy of space-like radiation effects (Fe 56 particles) on muscarinic neurotransmitter sensitivity and motor behavior
24. Magnesium activation of GTP hydrolysis or incubation in S-adenosyl-l- methionine reverses iron-56-particle-induced decrements in oxotremorine enhancement of K+-evoked striatal release of dopamine
25. CNS-induced deficits of heavy particle irradiation ins pace: The aging connection
26. 5-HT-3 receptor antagonists ameliorate emesis in the ferret evoked by neutron or proton irradiation
27. 56Fe radiation exposure
28. Late degeneration in rabbit tissues after irradiation by heavy ions
29. 56Fe ions on retinal photoreceptor cells of the rabbit: Implications for manned missions to Mars
30. How do tissues respond to damage at the cellular level? The role of cytokines in radiation response
31. Irradiation of rat tubule epithelial cells alters the expression of gene products associated with the synthesis and degradation of extracellular matrix
32. Modulation of lens cell adhesion molecules by particles
33. Cell communication: The inside story
34. Risk estimates for radiation-induced cancer-the epidemiological evidence
35. Tumorigenic potential of high-Z, high-LET charged-particle radiations
36. Fluence-based relativeOxford biological effectiveness for charged particle carcinogenesis in mouse harderian gland
37. On the shape of neutron dose-effect curves for radiogenic cancers and life shortening in mice
38. Dose response for skin tumors induced by single and split doses of argon ions
39. Amplification of the c-myc oncogene in radiation-induced rat skin tumors as a function of linear energy transfer and dose
40. The oncogenic transforming potential of the passage of single alpha particles through mammalian cell nuclei
41. Genomic instability, bystander effect, cytoplasmic irradiation and other phenomena that may achieve fame without fortune
42. The effect of high-energy accelerated particles on the crystalline lens of laboratory animals
43. Late ophthalmological complications after total body irradiation in non-human primates
44. Lens changes after proton beam irradiation for uveal melanoma
45. Helium-ion-induced human cataractogenesis
46. Anterior segment complications after helium ion radiation therapy for uveal melanoma. Radiation cataract
47. Use of subjective and nonsubjective methodologies to evaluate lens radiation damage in exposed populations-an overview
48. Proton radiation therapy (PRT) for pediatric optic pathway gliomas: Comparison with 3D planned conventional photons and a standard photon technique
49. Fractionated proton radiation therapy of cranial and intracranial tumors
50. Proton therapy for pediatric cranial tumors: Preliminary report on treatment and disease-related morbidities
51. Conformal proton therapy for prostate carcinoma
52. Clinical applications of proton therapy
53. Proton therapy in ophthalmology: Status report and problems encountered
54. Ultrasonographic follow-up of primary choroidal malignant melanoma after proton beam irradiation therapy
55. Potential role of proton therapy in the treatment of pediatric medulloblastoma/primitive neuroectodermal tumors: Reduction of the supratentorial target volume
56. Review of current protocols for protontherapy in USA
57. Results of proton therapy of uveal melanomas treated in Nice
58. Proton therapy for uveal melanomas and other eye lesions
59. The time course of irradiation changes in proton beam-treated uveal melanomas
60. Radiobiological significance of beamline dependent proton energy distributions in a spread-out Bragg peak
61. A semi-empirical approach to the evaluation of the relative biological effectiveness of therapeutic proton beams: The methodological framework
62. RBE-LET relationships for cell inactivation and mutation induced by low energy protons in V79 cells: Further results at the LNL facility
63. Proton radiobiology and uncertainties
64. Studies of physiology and the morphology fo the cat lgn following proton irradiation
65. Measuring the spectrum of mutation induced by nitrogen ions and protons in the human-hamster hybrid cell line A(L)C
66. 5-HT3 receptor antagonists ameliorate emesis in the ferret evoked by neutron or proton irradiation
67. Effectiveness of protons and argon ions in initiating lipid peroxidation in low-density lipoproteins
68. DNA complex lesions induced by protons and alpha-particles: Track structure characteristics determining linear energy transfer and particle type dependence
69. Acute effects of whole-body proton irradiation on the immune system of the mouse
70. Preliminary results of phase I/II carbon-ion therapy at the National Institute of Radiological Sciences
71. The phase I/II clinical study of carbon ion therapy for cancer of the uterine cervix
72. Biological verification of heavy ion treatment planning
73. Biophysical characteristics of HIMAC clinical irradiation system for heavy-ion radiation therapy
74. Detection of DNA damages and repair in human culture cells with simulated space radiation
75. Association between G2-phase block and repair of radiation-induced chromosome fragments in human lymphocytes
76. Chromosome breakage and cell lethality in human hepatoma cells irradiated with X rays and carbon-ion beams
77. Response of mouse intestine after single and fractionated irradiation with accelerated carbon ions with a spread-out Bragg peak
78. Cytotoxic effect of accelerated carbon beams on glioblastoma cell lines with p53 mutation: Clonogenic survival and cellcycle analysis
79. WAF1 accumulation by carbon-ion beam and alpha-particle irradiation in human glioblastoma cultured cells
80. Induction by carbon-ion irradiation of the expression of vascular endothelial growth factor in a lung carcinoma cell
81. RBE for carbon track-segment irradiation in cell lines of differing repair capacity
82. Repopulation in mouse oral mucosa: Changes in the effect of dose fractionation
83. Tumor therapy and track structure
84. Computation of cell survival in heavy ion beams for therapy. The model and its approximation
85. DNA double-strand breaks in mammalian cells exposed to gamma-rays and very heavy ions. Fragment-size distributions determined by pulsed-field gel electrophoresis
86. Investigation of lipid peroxidation in liposomes induced by heavy ion irradiation
87. Effect of high linear energy transfer radiation on biological membranes
88. Estimate of the frequency of true incomplete exchanges in human lymphocytes exposed to 1 GeV/u Fe ions in vitro
89. 20Ne-Ion beams
90. Biological monitoring of radiation exposure
91. Inter-laboratory comparison of cytogenetic endpoints for the biomonitoring of radiological workers
92. Cytogenetic analysis in human lymphocytes after exposure to simulated cosmic radiation which reflects the inflight radiation environment
93. Chromosomal aberrations induced in human lymphocytes by high-LET irradiation
94. Rejoining and misrejoining of radiation-induced chromatin breaks. IV. Charged particles
95. Stable chromosomal aberrations in haemopoietic stem cells in the blood of radiation accident victims
96. Chromosome analysis of workers occupationally exposed to radiation at the Sellafield nuclear facility
97. Chromosomal aberrations in blood lymphocytes of astronauts after long-term space flights
98. Manned missions to Mars and chromosome damage
99. Chromosomal alterations in peripheral lymphocytes of female cabin attendants
100. Background ionizing radiation plays a minor role in the production of chromosome translocations in a control population
101. 137Cs-γ or HZE-Fe ions
102. Genetic and cytogenetic markers of exposure to high-linear energy transfer radiation
103. Assessing exposure to cosmic radiation during long-haul flights
104. Dose-rate effects for apoptosis and micronucleus formation in gamma- irradiated human lymphocytes
105. Impact of p53 status on heavy-ion radiation-induced micronuclei in circulating erythrocytes
106. Assessment of DNA damage induced by high-LET ions in human lymphocytes using the comet assay
107. Detection of individual differences in radiation-induced apoptosis of peripheral blood lymphocytes in normal individuals, ataxia telangiectasia homozygotes and heterozygotes, and breast cancer patients after radiotherapy
108. Intrinsic radiosensitivity of healthy donors and cancer patients as determined by the lymphocyte micronucleus assay
109. Nucleic acid molecular biomarkers for diagnostic biodosimetry applications: Use of the fluorogenic 5′-nuclease polymerase chain reaction assay
110. High-LET-induced chromosome aberrations in V79 cells analysed in first and second postirradiation metaphases
111. Biodosimetry results from space flight Mir-18
112. Chromosome aberrations induced in human lymphocytes by 3.45 MeV alpha particles analyzed by premature chromosome condensation
113. Chromosome aberrations induced by light ions: Monte Carlo simulations based on a mechanistic model
114. Expression of cytoskeletal elements in proliferating cells following radiation exposure
115. Delayed expression of hpS2 and prolonged expression of CIP1/WAF1/SDI1 in human tumour cells irradiated with X-rays, fission neutrons or 1 GeV/nucleon Fe ions
116. Particle irradiation induces FGF-2 expression in normal human lens cells
117. Tumortherapy with ion beams
118. Treatment planning for heavy-ion radiotherapy: Physical beam model and dose optimization